STVN,Stevanato Group S.p.A. | Healthcare

Healthcare

STVN

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Stevanato Group S.p.A.STVN

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare.

The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A.

is a subsidiary of Stevanato Holding S.R.L.

Latest News >

Why NKGen Biotech (NKGN) Stock Is Skyrocketing

Jul 18, 2024

NKGen Biotech Inc ( NKGN ) shares are trading higher by 25% to $1.17 Thursday morning after the company announced it will present new SNK01 biomarker data at the Alzheimer’s Association International Conference. NKGen Biotech ( NKGN ) says the data will be presented at the conference in Philadelphia and online from July 28 to August 1, 2024. The data...

OpenAI unveils cheaper small AI model GPT-4o mini

Jul 18, 2024

(Reuters) - ChatGPT maker OpenAI said on Thursday it was launching GPT-4o mini, a cost-efficient small AI model, aimed at making its technology more affordable and less energy intensive, allowing the startup to target a broader pool of customers. Microsoft-backed OpenAI, which is the market leader in the AI software space, has been working to make it cheaper and faster...

Abbott Laboratories Tops Second-Quarter Views, Lifts Earnings Outlook

Jul 18, 2024

11:06 AM EDT, 07/18/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) reported bigger-than-expected increases in second-quarter results on Thursday amid revenue growth in medical device and nutrition while the healthcare company raised its full-year earnings forecast. Revenue advanced to $10.38 billion for the three months ended June 30 from $9.98 billion a year ago and topped the $10.37 billion...

National Bank of Canada with Q2 Earnings Preview for Lithium Companies

Jul 18, 2024

11:04 AM EDT, 07/18/2024 (MT Newswires) -- National Bank of Canada on Wednesday provided a second-quarter earnings preview for lithium companies under its coverage. The bank said it expects Lithium Royalty ( LITRF ) to improve its revenue quarter over quarter, driven by the deferred receipt of revenue related to first-quarter sales from Sigma Lithium ( SGML ) and a...